CSPC Pharmaceutical Group Limited (CSPCY)
OTCMKTS · Delayed Price · Currency is USD
4.970
-0.040 (-0.80%)
Feb 6, 2026, 9:30 AM EST
CSPC Pharmaceutical Group Market Cap
CSPC Pharmaceutical Group has a market cap or net worth of $14.31 billion as of February 9, 2026. Its market cap has increased by 120.06% in one year.
Market Cap
14.31B
Enterprise Value
13.25B
Revenue
3.68B
Ranking
n/a
PE Ratio
25.08
Stock Price
$4.97
Market Cap Chart
Since December 4, 1995, CSPC Pharmaceutical Group's market cap has increased from 89.97M to 14.31B, an increase of 15,803.99%. That is a compound annual growth rate of 18.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 14.31B | 15.56% |
| Dec 31, 2025 | 12.38B | 74.34% |
| Dec 31, 2024 | 7.10B | -35.50% |
| Dec 29, 2023 | 11.01B | -12.12% |
| Dec 30, 2022 | 12.53B | -3.19% |
| Dec 31, 2021 | 12.94B | 5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 805.86M |
| Glass House Brands | 756.71M |
| Elite Pharmaceuticals | 481.05M |
| Northwest Biotherapeutics | 405.51M |
| Nika Pharmaceuticals | 403.38M |
| American Oncology Network | 377.98M |
| CytoDyn | 317.38M |
| OpGen | 310.55M |